In this study, patients who have had previous endoscopic sinus surgery and present with an acute exacerbation of chronic rhinosinusitis will be offered endoscopic-guided, culture-directed antibiotic therapy. They will then be randomized to receive oral or intranasal topical antibiotics. Both of these are considered standard of care, but there is some limited data suggesting superiority of topical antibiotics especially if guided by culture and in patients who have undergone previous surgery. However, a study that directly compares the two has not been published. Modified Lund-Kennedy endoscopic finding scores and subjective SNOT-22 questionnaires will be collected before and at 3-4 weeks after treatment. Medication-related sided effects will be noted and analyzed. After 6-8 month follow-up, we will analyze the rate of recurrence of exacerbations, need for further antibiotics, need for revision surgery, and SNOT-22 scores based on oral versus topical antibiotic treatment. Our objective is to evaluate both short and long-term response to both oral and topical administration of antibiotics in this patient population in order to determine if either route of administration is superior to the other.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Previously described in two arms
SNOT-22
Patient-centered, validated 22-item questionnaire assessing SinoNasal outcomes
Time frame: Baseline, 3-4 weeks after initiation, and at 6-8 months
Modified Lund-Kennedy Score
Endoscopic grading score of sinonasal inflammation
Time frame: Baseline and 3-4 weeks after initiation
Antibiotic Side Effect Questions
Asking about adverse side effects
Time frame: 3-4 weeks after initiation
Final Questions
Asking about recurrence of infections, further need for antibiotics and surgeries
Time frame: 6-8 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.